Registro:

Referencias:

• Franks, S., Polycystic ovary syndrome (1995) NEngl J Med., 333, pp. 853-861
• Dunaif, A., Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis (1997) Endocr Rev., 18, pp. 774-800
• Carmeliet, P., Angiogenesis in health and disease (2003) Nat Med., 9, pp. 653-660
• Hoch, R.V., Soriano, P., Roles of PDGF in animal development (2003) Development, 130, pp. 4769-4784
• Betsholtz, C., Insight into the physiological functions of PDGF through genetic studies in mice (2004) Cytokine Growth Factor Rev., 15, pp. 215-228
• Andrae, J., Gallini, R., Betsholtz, C., Roleof platelet-derived growth factors in physiology and medicine (2008) Genes Dev., 22, pp. 1276-1312
• Pascuali, N., Scotti, L., Abramovich, D., Tesone, M., Parborell, F., (2012) New Role of PDGF (Platelet-Derived Growth Factor) in Ovarian Follicular Dynamics. Program of the XXIII Annual Reunion of the Chilean Society of Reproduction and Development, 102. , Viña del Mar, Chile Abstract
• Schmahl, J., Rizzolo, K., Soriano, P., The PDGF signaling pathway controls multiple steroid-producing lineages (2008) Genes Dev., 22, pp. 3255-3267
• Scotti, L., Parborell, F., Irusta, G., Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients (2014) Mol Reprod Dev., 81, pp. 748-756
• Scotti, L., Abramovich, D., Pascuali, N., Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS) (2013) Mol Cell Endocrinol., 365, pp. 223-230
• Kamat, B.R., Brown, L.F., Manseau, E.J., Senger, D.R., Dvorak, H.F., Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development (1995) Am J Pathol., 146, pp. 157-165
• Stanek, M.B., Borman, S.M., Molskness, T.A., Larson, J.M., Stouffer, R.L., Patton, P.E., Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: Comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women (2007) J Clin Endocrinol Metab., 92, pp. 2726-2733
• Agrawal, R., Tan, S.L., Wild, S., Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome (1999) Fertil Steril., 71, pp. 287-293
• Agrawal, R., Sladkevicius, P., Engmann, L., Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries (1998) Hum Reprod., 13, pp. 651-655
• Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohí, J., Simón, C., The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor (1999) Fertil Steril., 71, pp. 482-489
• Corton, J.M., Gillespie, J.G., Hardie, D.G., Role of the AMP-activated protein kinase in the cellular stress response (1994) Curr Biol., 4, pp. 315-324
• Zhou, G., Myers, R., Li, Y., Role of AMP-activated protein kinase in mechanism of metformin action (2001) J Clin Invest., 108, pp. 1167-1174
• Ayaz, A., Alwan, Y., Farooq, M.U., Efficacy of combined metforminclomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS) (2013) J Med Life, 6, pp. 199-201
• Velija-Ašimi, Z., Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment (2013) Bosn J Basic Med Sci., 13, pp. 180-185
• Velazquez, E.M., Mendoza, S., Hamer, T., Sosa, F., Glueck, C.J., Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy (1994) Metabolism, 43, pp. 647-654
• Jungheim, E.S., Odibo, A.O., Fertility treatment in women with polycystic ovary syndrome: A decision analysis of different oral ovulation induction agents (2010) Fertil Steril., 94, pp. 2659-2664
• Johnson, N., Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-a meta-analysis of randomised trials (2011) Aust NZ J Obstet Gynaecol., 51, pp. 125-129
• Tang, T., Lord, J.M., Norman, R.J., Yasmin, E., Balen, A.H., Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility (2012) Cochrane Database Syst Rev., 5, p. CD003053
• Palomba, S., Falbo, A., La Sala, G.B., Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: A systematic review and meta-analysis of randomised controlled trials (2013) BJOG, 120, pp. 267-276
• Palomba, S., Falbo, A., La Sala, G.B., Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: A systematic review with meta-analysis of randomized controlled trials (2014) Reprod Biol Endocrinol., 12, p. 3
• Moll, E., Van Der Veen, F., Van Wely, M., The role of metformin in polycystic ovary syndrome: A systematic review (2007) Hum Reprod Update, 13, pp. 527-537
• Kjøtrød, S.B., Carlsen, S.M., Rasmussen, P.E., Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: A prospective, randomized, double-blind, multi-centre study (2011) Hum Reprod., 26, pp. 2045-2053
• Consensus on infertility treatment related to polycystic ovary syndrome (2008) Hum Reprod., 23, pp. 462-477
• Siebert, T.I., Viola, M.I., Steyn, D.W., Kruger, T.F., Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis (2012) Gynecol Obstet Invest., 73, pp. 304-313
• Martin, M.J., Hayward, R., Viros, A., Marais, R., Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A (2012) Cancer Discov., 2, pp. 344-355
• Cittadini, A., Napoli, R., Monti, M.G., Metformin prevents the development of chronic heart failure in the SHHF rat model (2012) Diabetes, 61, pp. 944-953
• Phoenix, K.N., Vumbaca, F., Claffey, K.P., Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model (2009) Breast Cancer Res Treat., 113, pp. 101-111
• Soraya, H., Esfahanian, N., Shakiba, Y., Anti-angiogenic effects of metformin, an AMPK activator, on human umbilical vein endothelial cells and on granulation tissue in rat (2012) Iran J Basic Med Sci., 15, pp. 1202-1209
• Rattan, R., Graham, R.P., Maguire, J.L., Giri, S., Shridhar, V., Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo (2011) Neoplasia, 13, pp. 483-491
• Liao, H., Zhou, Q., Gu, Y., Duan, T., Feng, Y., Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway (2012) Oncol Rep., 27, pp. 1873-1878
• Shank, J.J., Yang, K., Ghannam, J., Metformin targets ovarian cancer stem cells in vitro and in vivo (2012) Gynecol Oncol., 127, pp. 390-397
• Wu, B., Li, S., Sheng, L., Metformin inhibits the development and metastasis of ovarian cancer (2012) Oncol Rep., 28, pp. 903-908
• Abdelsaid, M., Kaczmarek, J., Coucha, M., Ergul, A., Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: Relevance to glycemic control (2014) Life Sci., 118, pp. 268-273
• Dallaglio, K., Bruno, A., Cantelmo, A.R., Paradoxic effects of metformin on endothelial cells and angiogenesis (2014) Carcinogenesis, 35, pp. 1055-1066
• Tan, B.K., Adya, R., Chen, J., Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1 (2009) Cardiovasc Res., 83, pp. 566-574
• Tan, B.K., Adya, R., Farhatullah, S., Chen, J., Lehnert, H., Randeva, H.S., Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome (2010) Diabetes, 59, pp. 3023-3031
• Elia, E.M., Quintana, R., Carrere, C., Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study (2013) J Ovarian Res., 6, p. 62
• Khattab, S., Fotouh, I.A., Mohesn, I.A., Metwally, M., Moaz, M., Use of metformin for prevention of ovarian hyperstimulation syndrome: A novel approach (2006) Reprod Biomed Online, 13, pp. 194-197
• Palomba, S., Falbo, A., Carrillo, L., Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: A randomized, controlled trial (2011) Fertil Steril., 96, pp. 1384.e4-1390.e4
• Walters, K.A., Allan, C.M., Handelsman, D.J., Rodent models for human polycystic ovary syndrome (2012) Biol Reprod., 86, pp. 1491-14912
• Anderson, E., Lee, G.Y., The polycystic ovarian (PCO) condition: Apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model (1997) Tissue Cell, 29, pp. 171-189
• Henmi, H., Endo, T., Nagasawa, K., Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats (2001) Biol Reprod., 64, pp. 157-162
• Honnma, H., Endo, T., Henmi, H., Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats (2006) Apoptosis, 11, pp. 1525-1533
• Solano, M.E., Elia, E., Luchetti, C.G., Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice (2006) Reprod Fertil Dev., 18, pp. 533-544
• Abramovich, D., Irusta, G., Bas, D., Cataldi, N.I., Parborell, F., Tesone, M., Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome (2012) Endocrinology, 153, pp. 3446-3456
• Sander, V., Luchetti, C.G., Solano, M.E., Role of the N, N′-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone (2006) Reproduction, 131, pp. 591-602
• Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited (2008) FASEB J., 22, pp. 659-661
• Woodruff, T.K., Lyon, R.J., Hansen, S.E., Rice, G.C., Mather, J.P., Inhibin and activin locally regulate rat ovarian folliculogenesis (1990) Endocrinology, 127, pp. 3196-3205
• Andreu, C., Parborell, F., Vanzulli, S., Chemes, H., Tesone, M., Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis (1998) Mol Reprod Dev., 51, pp. 287-294
• Sadrkhanloo, R., Hofeditz, C., Erickson, G.F., Evidence for widespread atresia in the hypophysectomized estrogen-treated rat (1987) Endocrinology, 120, pp. 146-155
• Convery, M., McCarthy, G.F., Brawer, J.R., Remission of the polycystic ovarian condition (PCO) in the rat following hemiovariectomy (1990) Anat Rec., 226, pp. 328-336
• Lara, H.E., Dissen, G.A., Leyton, V., An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat (2000) Endocrinology, 141, pp. 1059-1072
• Díaz-Torga, G.S., Mejia, M.E., González-Iglesias, A., Metabolic cues for puberty onset in free grazing Holstein heifers naturally infected with nematodes (2001) Theriogenology, 56, pp. 111-122
• Silveyra, P., Catalano, P.N., Lux-Lantos, V., Libertun, C., Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: Actions of Cetrorelix and Nembutal (2007) Am J Physiol Endocrinol Metab., 292, pp. E820-E828
• De Leo, V., Musacchio, M.C., Piomboni, P., Di Sabatino, A., Morgante, G., The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications (2011) Eur J Obstet Gynecol Reprod Biol., 157, pp. 63-66
• Sohrabvand, F., Shariat, M., Haghollahi, F., Bagheri, B., Effect of metformin on miscarriage in pregnant patients with polycystic ovary syndrome (2009) West Indian Med J., 58, pp. 433-436
• Tso, L.O., Costello, M.F., Albuquerque, L.E., Andriolo, R.B., Freitas, V., Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome Cochrane Database Syst Rev., , 2009CD006105
• Esfahanian, N., Shakiba, Y., Nikbin, B., Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells (2012) Mol Med Rep., 5, pp. 1068-1074
• Zaafar, D.K., Zaitone, S.A., Moustafa, Y.M., Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: Effect on tumor angiogenesis and cell proliferation (2014) PLoS One, 9, p. e100562
• Ersoy, C., Kiyici, S., Budak, F., The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients (2008) Diabetes Res Clin Pract., 81, pp. 56-60
• Yilmaz, B., Sucak, A., Kilic, S., Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 (2010) Am J Obstet Gynecol., 202, p. 368
• Mick, G.J., Wang, X., McCormick, K., White adipocyte vascular endothelial growth factor: Regulation by insulin (2002) Endocrinology, 143, pp. 948-953
• Chou, E., Suzuma, I., Way, K.J., Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: A possible explanation for impaired collateral formation in cardiac tissue (2002) Circulation, 105, pp. 373-379
• Lu, M., Amano, S., Miyamoto, K., Insulin-induced vascular endothelial growth factor expression in retina (1999) Invest Ophthalmol Vis Sci., 40, pp. 3281-3286
• Hale, L.J., Hurcombe, J., Lay, A., Insulin directly stimulates VEGF-Aproduction in the glomerular podocyte (2013) Am J Physiol Renal Physiol., 305, pp. F182-F188
• Begum, M.R., Akhter, S., Ehsan, M., Begum, M.S., Khan, F., Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome (2013) J Obstet Gynaecol Res., 39, pp. 966-973
• Morin-Papunen, L., Rantala, A.S., Unkila-Kallio, L., Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-blind, placebo-controlled randomized trial (2012) J Clin Endocrinol Metab., 97, pp. 1492-1500
• McNeilly, A.S., Duncan, W.C., Rodent models of polycystic ovary syndrome (2013) Mol Cell Endocrinol., 373, pp. 2-7

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------